NAPRELAN® should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients.

References: 1. NAPRELAN® Prescribing information, Victory Pharma, Inc., San Diego, CA
References: 3. Data on file, Victory Pharma, Inc., San Diego, CA

Please see full prescribing information including BOXED warnings regarding cardiovascular and gastrointestinal risks.

IPDAS
indications
onset & duration
tolerability
frequently asked questions
prescribing information
symptoms & diagnosis
treatment
tips
other indications
prescribing information